IOL CHEMICALS & PHARM. | GLENMARK PHARMA | IOL CHEMICALS & PHARM./ GLENMARK PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | -35.4 | - | View Chart |
P/BV | x | 1.6 | 3.2 | 48.2% | View Chart |
Dividend Yield | % | 1.0 | 0.2 | 432.8% |
IOL CHEMICALS & PHARM. GLENMARK PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
GLENMARK PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ GLENMARK PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 487 | 110.2% | |
Low | Rs | 272 | 349 | 78.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 460.4 | 82.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 13.4 | 177.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 35.0 | 90.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.50 | 160.0% | |
Avg Dividend yield | % | 1.0 | 0.6 | 165.4% | |
Book value per share (Unadj.) | Rs | 256.8 | 335.1 | 76.6% | |
Shares outstanding (eoy) | m | 58.71 | 282.17 | 20.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.9 | 117.9% | |
Avg P/E ratio | x | 17.1 | 31.3 | 54.6% | |
P/CF ratio (eoy) | x | 12.8 | 11.9 | 107.4% | |
Price / Book Value ratio | x | 1.6 | 1.2 | 126.3% | |
Dividend payout | % | 16.9 | 18.7 | 90.3% | |
Avg Mkt Cap | Rs m | 23,743 | 117,953 | 20.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 27,810 | 6.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 129,901 | 17.1% | |
Other income | Rs m | 256 | 3,168 | 8.1% | |
Total revenues | Rs m | 22,427 | 133,069 | 16.9% | |
Gross profit | Rs m | 2,257 | 15,125 | 14.9% | |
Depreciation | Rs m | 462 | 6,113 | 7.6% | |
Interest | Rs m | 165 | 3,496 | 4.7% | |
Profit before tax | Rs m | 1,887 | 8,685 | 21.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 4,911 | 10.1% | |
Profit after tax | Rs m | 1,391 | 3,774 | 36.9% | |
Gross profit margin | % | 10.2 | 11.6 | 87.4% | |
Effective tax rate | % | 26.2 | 56.5 | 46.4% | |
Net profit margin | % | 6.3 | 2.9 | 216.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 98,737 | 9.8% | |
Current liabilities | Rs m | 5,025 | 50,455 | 10.0% | |
Net working cap to sales | % | 20.9 | 37.2 | 56.3% | |
Current ratio | x | 1.9 | 2.0 | 98.3% | |
Inventory Days | Days | 43 | 7 | 646.0% | |
Debtors Days | Days | 8 | 115 | 7.2% | |
Net fixed assets | Rs m | 11,017 | 76,920 | 14.3% | |
Share capital | Rs m | 587 | 282 | 208.1% | |
"Free" reserves | Rs m | 14,490 | 94,281 | 15.4% | |
Net worth | Rs m | 15,077 | 94,563 | 15.9% | |
Long term debt | Rs m | 0 | 38,521 | 0.0% | |
Total assets | Rs m | 20,684 | 175,658 | 11.8% | |
Interest coverage | x | 12.5 | 3.5 | 357.4% | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 144.9% | |
Return on assets | % | 7.5 | 4.1 | 181.8% | |
Return on equity | % | 9.2 | 4.0 | 231.2% | |
Return on capital | % | 13.6 | 9.2 | 148.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 46,464 | 12.8% | |
Fx outflow | Rs m | 6,052 | 12,712 | 47.6% | |
Net fx | Rs m | -122 | 33,751 | -0.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 6,254 | 19.6% | |
From Investments | Rs m | -1,200 | -5,285 | 22.7% | |
From Financial Activity | Rs m | -41 | -775 | 5.3% | |
Net Cashflow | Rs m | -18 | 325 | -5.7% |
Indian Promoters | % | 48.2 | 46.6 | 103.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 34.8 | 4.9% | |
FIIs | % | 1.4 | 21.4 | 6.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 53.4 | 97.1% | |
Shareholders | 130,003 | 199,451 | 65.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Glenmark Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | 0.77% | 0.97% |
1-Month | 5.64% | 12.95% | 2.08% |
1-Year | -1.14% | 108.27% | 55.37% |
3-Year CAGR | -12.91% | 25.04% | 15.04% |
5-Year CAGR | 16.34% | 11.04% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Glenmark Pharma share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Glenmark Pharma the stake stands at 46.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Glenmark Pharma.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Glenmark Pharma.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.